The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.
Annovera is a reusable donut-shaped (ring), non-biodegradable, flexible vaginal system that is placed in the vagina for three weeks followed by one week out of the vagina, at which time women may experience a period (a withdrawal bleed). This schedule is repeated every four weeks for one year (thirteen 28-day menstrual cycles).
Annovera is washed and stored in a compact case for the seven days not in use. Annovera does not require refrigeration prior to dispensing and can withstand storage temperatures up to 30°C (86°F).
Annovera contains Segesterone acetate as a long acting progesterone which is highly effective given in the transdermal fashion.
The potential benefits could be huge. Less chance of abnormal bleeding from missing pills and taking them at wrong times, no need to carry pills around in your bag, no worries about being able to get enough supply if you are traveling around the world are some of the advantages we can look forward to.
The risks and contraindications are the same as for any other hormonal birth control such as pills or patch.
We are hoping that the convenience factor and that women do not have to go to the pharmacy every month to pick up a refill are a big plus. Hopefully, the cost is within reach!! Let’s see when it shows up on the market…
Stay tuned
Dr. Adeeti Gupta